Maia Szalavitz is the author, most recently, of Unbroken Brain: A Revolutionary New Way of Understanding Addiction, which will be released in paperback in May. She has written about neuroscience and addiction for nearly 30 years for publications ranging from the New York Times and Washington Post to TIME and Scientific American.
Maia Szalavitz
Neuroscience Journalist
Freelance
From this contributor
Autism’s hidden habit
Conventional wisdom holds that people with autism don't get hooked on alcohol or other drugs, but new evidence suggests otherwise.
New tests extend prospects for ‘reading the mind in the eyes’
Researchers have revamped a screen for ‘mind blindness’ — an impaired understanding of others’ intentions and perspectives — which is a key deficit in autism. The revised test may shed light on how autism develops.
New tests extend prospects for ‘reading the mind in the eyes’
By
Maia Szalavitz
8 April 2014 | 3 min read
‘Resting’ autism brains still hum with activity
Even at rest, the brains of people with autism manage more information than those of their peers, according to a new study that may provide support for the so-called ‘intense world’ theory of autism.
‘Resting’ autism brains still hum with activity
By
Maia Szalavitz
21 February 2014 | 3 min read
First 1,000 days of life could hold keys to autism
Autism researchers have high hopes for a new project called the First 1,000 Days of Life, which aims to follow 5,000 women and their babies from pregnancy through two years after birth.
First 1,000 days of life could hold keys to autism
By
Maia Szalavitz
17 February 2014 | 4 min read
Long neglected, severe cases of autism get some attention
A large new project aims to link specialized psychiatric units across the U.S. to investigate the causes and best treatment for autism’s most severe and challenging cases.
Long neglected, severe cases of autism get some attention
By
Maia Szalavitz
19 December 2013 | 5 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read